Literature DB >> 14999383

[HIV/AIDS competence network research group presents first results].

N H Brockmeyer1, G Reimann, V Zylka-Menhorn.   

Abstract

Germany's clinical HIV research efforts are underrepresented on an international level. This deficit is primarily due to a lack of clinical studies involving patients from across the country and the fact that no national patient cohort system exists in Germany which could provide a basis for such clinical studies. The competence network HIV/AIDS is filling this shortcoming by serving as a comprehensive, nationwide research alliance. The establishment of a patient cohort is linked to 20 projects. The success of this new structure is becoming visible.

Entities:  

Mesh:

Year:  2004        PMID: 14999383     DOI: 10.1007/s00108-004-1157-z

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  7 in total

1.  Frequency of genotypic and phenotypic drug-resistant HIV-1 among therapy-naive patients of the German Seroconverter Study.

Authors:  S Duwe; M Brunn; D Altmann; O Hamouda; B Schmidt; H Walter; G Pauli; C Kücherer
Journal:  J Acquir Immune Defic Syndr       Date:  2001-03-01       Impact factor: 3.731

2.  HIV-1 p24 but not proviral load is increased in the intestinal mucosa compared with the peripheral blood in HIV-infected patients.

Authors:  O T Fackler; M Schäfer; W Schmidt; T Zippel; W Heise; T Schneider; M Zeitz; E O Riecken; N Mueller-Lantzsch; R Ullrich
Journal:  AIDS       Date:  1998-01-22       Impact factor: 4.177

3.  Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.

Authors:  J L Jones; D L Hanson; M S Dworkin; D L Alderton; P L Fleming; J E Kaplan; J Ward
Journal:  MMWR CDC Surveill Summ       Date:  1999-04-16

4.  Supernatants of HIV-infected immune cells affect the barrier function of human HT-29/B6 intestinal epithelial cells.

Authors:  Heinz Schmitz; Katharina Rokos; Peter Florian; Alfred H Gitter; Michael Fromm; Peter Scholz; Reiner Ullrich; Martin Zeitz; Georg Pauli; Jörg-Dieter Schulzke
Journal:  AIDS       Date:  2002-05-03       Impact factor: 4.177

5.  [Hepatitis C and HIV coinfection. Current aspects of therapy].

Authors:  J K Rockstroh
Journal:  MMW Fortschr Med       Date:  2002-04-09

Review 6.  Primary HIV infection.

Authors:  Ade Apoola; Sammena Ahmad; Keith Radcliffe
Journal:  Int J STD AIDS       Date:  2002-02       Impact factor: 1.359

7.  Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection.

Authors:  Nazifa Qurishi; Christina Kreuzberg; Guido Lüchters; Wolfgang Effenberger; Bernd Kupfer; Tilman Sauerbruch; Jürgen K Rockstroh; Ulrich Spengler
Journal:  Lancet       Date:  2003-11-22       Impact factor: 79.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.